BioCardia, Inc.
Cash Flow Statement
| Line Item | FY2017 | FY2016 | FY2015 | FY2014 | FY2013 | FY2012 | FY2011 | FY2010 |
|---|---|---|---|---|---|---|---|---|
| Operating Activities | ||||||||
| Net Income | $-12.3M | $-10.3M | $-6.7M | $234.0K | $19.0K | $305.0K | $9.7M | $-11.5M |
| Depreciation & Amortization | $78.0K | $39.0K | $47.0K | — | — | — | $0 | $967.0K |
| Depreciation | $78.0K | $39.0K | $47.0K | — | — | — | — | — |
| Amortization | — | — | — | — | — | — | — | — |
| Stock-Based Compensation | $2.7M | $942.0K | $283.0K | $0 | $2.0K | $6.0K | $37.0K | $51.0K |
| Net Cash from Operating Activities | $-8.7M | $-5.5M | $-7.0M | $214.0K | $27.0K | $-310.0K | $-3.1M | $-4.3M |
| Investing Activities | ||||||||
| Capital Expenditures | $136.0K | — | $125.0K | — | — | $0 | $137.0K | $1.1M |
| Business Acquisitions | — | — | — | — | — | — | — | — |
| Net Cash from Investing Activities | $-136.0K | $18.9M | $-125.0K | — | $0 | $900.0K | $16.1M | $-1.1M |
| Financing Activities | ||||||||
| Dividends Paid | — | — | — | — | — | — | — | — |
| Stock Repurchases | — | — | — | — | — | — | — | — |
| Net Cash from Financing Activities | $144.0K | $4.4M | $7.5M | — | — | $0 | $-500.0K | $500.0K |
| Net Change in Cash | — | — | $331.0K | $214.0K | $27.0K | $590.0K | $12.6M | $-4.8M |
| Free Cash Flow | $-8.8M | — | $-7.1M | — | — | $-310.0K | $-3.2M | $-5.3M |